Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 1;48(4):e207513.
doi: 10.14503/THIJ-20-7513.

Sudden Cardiac Death in Athletes

Darren C Tsang  1 , Mark S Link  1
Affiliations

Sudden Cardiac Death in Athletes

Darren C Tsang et al. Tex Heart Inst J. .
No abstract available

Keywords: Arrhythmias, cardiac; arrhythmogenic right ventricular cardiomyopathy; athletes; cardiomyopathies; cardiomyopathy, hypertrophic; cardiovascular abnormalities; commotio cordis; death, sudden, cardiac; sports.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Illustration shows variables and proposed mechanism of commotio cordis. Several variables of commotio cordis have been described in animal models and include characteristics of the impact object such as shape, hardness, diameter, and velocity. In addition, cell membrane stretching likely leads to ion channel activation, which increases the dispersion of repolarization and provides the substrate for ventricular fibrillation. K+ATP = ATP-sensitive potassium; LV = left ventricle Reprinted with permission from Link MS, Estes NAM. Athletes and arrhythmias. J Cardiovasc Electrophysiol 2010;21(10):1184–9.
See this image and copyright information in PMC

References

    1. Maron BJ. Sudden death in young athletes. N Engl J Med . 2003;349(11):1064–75. - PubMed
    1. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation . 2020;142(25):e533–57. - PubMed
    1. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. Circulation . 2015;132(22):e256–61. - PubMed
    1. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NAM, 3rd et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation . 2015;132(22):e273–80. - PubMed
    1. Pelliccia A, Solberg EE, Papadakis M, Adami PE, Biffi A, Caselli S et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC) Eur Heart J . 2019;40(1):19–33. - PubMed

LinkOut - more resources